Journal articleMol Cancer Ther2025
Olaparib and Radiotherapy Induce Type I Interferon- and CD8+ T Cell-Dependent Sensitization to Immunotherapy in Pancreatic Cancer.
- Journal
- Mol Cancer Ther
- Published
- 1 June 2025
- Citations
- 3
- Type
- Article
These are bibliographic fields. A study card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess. Only its metadata is loaded so far, so most questions will be declined.
Try
Grants 5
- Administrative Supplement P30 Cancer Center Support Grant (CCSG): Phase 1 Study of Olaparib in Combination with Durvalu… P30CA046592↗
- Molecularly Targeted Radiosensitization of Locally Advanced Cancers P50CA269022↗
- Targeting the DNA damage response in combination with radiation to induce innate immunity and improve immunotherapy eff… R01CA240515↗
- Improving the efficacy of radiotherapy by targeting the DNA damage response, tumor immunology and tumor metabolism R50CA251960↗
- Sensitization to Chemoradiation by Therapeutic Targeting of the DNA Damage Response U01CA216449↗